Vilin Bio Med Stock Price Analysis and Quick Research Report. Is Vilin Bio Med an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Vilin Bio Med. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Vilin Bio Med has a PE ratio of 211.922596754057 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Vilin Bio Med has ROA of 0.7434% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Vilin Bio Med has a Current ratio of 2.7485.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Vilin Bio Med has a ROE of 0.9738%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Vilin Bio Med has a Debt to Equity ratio of 0.1116 which means that the company has low proportion of debt in its capital.

• Sales growth: Vilin Bio Med has reported revenue growth of -6.2955% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Vilin Bio Med for the current financial year is 5.31266247577635%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Vilin Bio Med is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Vilin Bio Med is Rs 0.1602. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Vilin Bio Med in Ticker for free. Also, one can get the intrinsic value of Vilin Bio Med by using Valuation Calculators, which are available with a Finology ONE subscription. 

Vilin Bio Med FAQs

Q1. What is Vilin Bio Med share price today?
Ans: The current share price of Vilin Bio Med is Rs 33.95.

Q2. What is the market capitalisation of Vilin Bio Med?
Ans: Vilin Bio Med has a market capitalisation of Rs 47.36025 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Vilin Bio Med?
Ans: The PE ratio of Vilin Bio Med is 211.922596754057 and the P/B ratio of Vilin Bio Med is 2.05346881993589, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Vilin Bio Med share?
Ans: The 52-week high share price of Vilin Bio Med is Rs 38.4, and the 52-week low share price of Vilin Bio Med is Rs 16.5.

Q5. Does Vilin Bio Med pay dividends?
Ans: Currently, Vilin Bio Med does not pay dividends. Dividend yield of Vilin Bio Med is around 0%.

Q6. What are the face value and book value of Vilin Bio Med shares?
Ans: The face value of Vilin Bio Med shares is Rs 10, while the book value per share of Vilin Bio Med is around Rs 16.533. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Vilin Bio Med?
Ans: Vilin Bio Med has a total debt of Rs 2.5733 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Vilin Bio Med?
Ans: The ROE of Vilin Bio Med is 0.9738% and ROCE of Vilin Bio Med is 4.1619%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Vilin Bio Med a good buy for the long term?
Ans: The Vilin Bio Med long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Vilin Bio Med undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Vilin Bio Med appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Vilin Bio Med’s financials?
Ans: You can review Vilin Bio Med’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.